Chromosomal aberrations in Korean nonsmall cell lung carcinomas: Degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization studies

Cancer Genetics and Cytogenetics

Volumn 152, Issue 2, 2004, Pages 153-157

  Park, Soo Yeun ^a   Kim, Yeol Hong ^b   In, Kwang Ho ^b   Chun, Yong Hyuck ^c   Park, Sun Hwa ^c  

^a Ewha Womans University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Brain Korea 21 Biomed Sci K   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME YQ; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; KOREA; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DNA PRIMERS; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; KOREA; LUNG NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 3242683293     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.10.016     Document Type: Article

References (35)

1. Forozan F., Karhu R., Kononen J., Kallioniemi A., Kallioniemi O.-P. Genome screening by comparative genomic hybridization. Trends Genet. 13:1997;405-409
2. Telenius H., Carter N.P., Bebb C.E., Nordenskjold M., Ponder B.A.J., Runnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics. 13:1992;718-725
3. Minna J.D., Pass H., Glaststein E., Ihdl D. Cancer of the lung. De Vita V.T., Hellman S., Sosenberg S.A. Cancer principles and practice of oncology. 1989;591-705 J.B. Lippincott Press, Philadelphia
4. Annual report of the Korea Central Cancer Registry (KCCR) program. Headquarters of Korea central cancer registry, 2002.
5. Huang Q, Schantz SP, Rao PH, Mo J, McCormick SA, Chaganti RSK. Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. 2000;28:395-403.
6. Balsara B.R., Sonoda G., Manoir S., Siegfried J.M., Gabrielson E., Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell carcinomas. Cancer Res. 57:1997;2116-2120
7. Bjorkqvist A.M., Mannilehto I., Nordling S., Nurminen M., Anttila S., Mattson K., Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer. 77:1998;260-269
8. Bjorkqvist A.M., Husgafvel-Pursiainen K., Anttila S., Karjalainen A., Tammilehto L., Mattson K., Vainio H., Knuutila S. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer. 22:1998;79-82
9. Petersen I., Bujard M., Petersen S., Wolf G., Goeze A., Schwendel A., Langreck H., Gellert K., Reichel M., Just K., du Manoir S., Cremer T., Dietel M., Ried T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 57:1997;2331-2335
10. Ruk C., Tsao M.-S., Bayani J., Shepherd F., Squire J.A. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet. 125:2001;87-99
11. Pei J., Balsara B.R., Li W., Litwin S., Gabrielson E., Feder M., Jen J., Testa J.R. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer. 31:2001;282-287
12. Takai S., Long J.E., Yamada K., Miki T. Chromosomal localization of the human ECT2 proto-oncogene to 3q26.1∼q26.2 by somatic cell analysis and fluorescence in situ hybridization. Genomics. 27:1995;220-222
13. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 21:1999;99-102
14. Byun D.S., Cho K., Lee M.G., Park J.I., Chae K.S., Kim H.J., Chi S.G. Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma. Int J Cancer. 1004:2003;318-327
15. Redon R., Muller D., Caulee K., Wanherdrick K., Abecassis J., du Manoir S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res. 61:2001;4122-4129
16. Volm M., Efferth T., Mattern J. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res. 12:1992;11-20
17. Brennan J., O'Connor T., Makuch R.W., Simmons A.M., Russell E., Linnoila R.I., Phelps R.M., Gazdar A.F., Ihde D.C., Johnson B.E. myc family DNA amplification in 107 tumors and tumor cell lines from patients with small-cell lung cancer treated with different combination chemotherapy regimens. Cancer Res. 51:1991;358-371
18. Mahlamaki E.H., Barlund M., Tanner M., Gorunova L., Hoglund M., Karhu R., Kallioniemi A. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer. 35:2002;353-358
19. Wong M.P., Fung L.-F., Wang E., Chow W.-S., Chiu S.-W., Lam W.-K., Ho K.-K., Ma E., Wan T., Chung L.-P. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers. Cancer. 97:2003;1263-1270
20. Knuutilal S., Autio K., Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am J Pathol. 157:2000;689
21. Schleiermacher G., Janoueix-Lerosey I., Combaret V., Derre J., Couturier J., Aurias A., Delattre O. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet. 141:2003;32-42
22. Lillington D.M., Kingston J.E., Coen P.G., Price E., Hungerford J., Domizio P., Young B.D., Onadim Z. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer. 36:2003;121-128
23. Hislop R.G., Pratt N., Stocks S.C., Steel C.M., Sales M., Boudie D., Robertson A., Thompson A.M. Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br J Surg. 89:2002;1581-1586
24. Huang W.C., Taylor S., Nguyen T.B., Romaszewski J.E., Libertino J.A., Malkowicz S.B., McGarvey T.W. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer. DNA Cell Biol. 21:2002;707-715
25. Nakatani K., Thompson D.A., Barthel A., Sakaue H., Liu W., Weigel R.J., Roth R.A. Up-regulation of Akt2 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem. 274:1999;21528-21532
26. Mitelman F., Johansson B., Mandahl N., Mertens F. Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet. 95:1997;1-8
27. Decker H.J.H., Weidt E.J., Brieger J. The von Hippel-Lindau tumor suppressor gene: a rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet. 93:1997;74-83
28. Sozzi G., Beronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Ohta M., Huebner K., Croce C.M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell. 85:1996;17-26
29. Simon B., Bartsch D., Barth P., Prasnikar N., Munch K., Blum A., Arnold R., Göke B. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Cancer Res. 58:1998;1583-1587
30. Virgilio L., Shuster M., Gollin S.M., Veronese M.L., Ohta M., Huebner K., Croce C.M. FHIT gene alterations in head, and neck squamous cell carcinomas. Proc Natl Acad Sci USA. 93:1996;9770-9775
31. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., Heubner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site, and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:1996;587-597
32. Chujo M., Noguchi T., Miura T., Arinaga M., Uchida Y., Tagawa Y. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer. 38:2002;23-29
33. Brass N., Ukena I., Remberger K., Mack U., Sybrecht G.W., Meese E.U. DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer. 32A:1996;1205-1208
34. Kettunen E., El-Rifai W., Bjorkqvist A.-M., Wolff H., Karjalainen A., Anttila S., Mattson K., Husgafvel-Pursiainen K., Knuutila S. A broad amplification pattern at 3q in squamous cell lung cancer - a fluorescence in situ hybridization study. Cancer Genet Cytogenet. 117:2000;66-70
35. Soder A.I., Going J.J., Kaye S.B., Keith W.N. Tumor specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene. 16:1998;979-983